Nice shoutout in the Society of Surgical Oncology Great Debates to Dr. Alexander Meves Alexander Meves Mayo Clinic Mayo Clinic Comprehensive Cancer Center SkylineDx work on GEP to predict SLN status for #melanoma patients and where we need a prospective clinical trial

New validation data on the Merlin test for #melanoma risk assessment by @WVUMedicine, Mayo Clinic, Mayo Clinic Center for Individualized Medicine and @SkylineDx: lnkd.in/gXmqZgg

Less then two weeks ago SkylineDx & Biocartis announced collaboration in #melanoma. Today, #MelanomaMonday, reminds us that melanoma is the deadliest form of #skincancer. Check how to protect your skin: aad.org/public/disease… #MelanomaAwarenessMonth

New collaborative paper online on how Merlin Test reduces unnecessary surgeries and associated complications 👇 skylinedx.com/news/merlin-te… #melanoma #diagnostics #MerlinTest

.Mayo Clinic experts talk about innovative #melanoma therapies grounded in collaborative research and practice. mayocl.in/34xRhk3 #CancerResearch #CME #MedProf

At the SkylineDX investigators breakfast discussing Merlin Trial with the PIs for the trial Tina J Hieken MD Michael Lowe Christina Angeles MD Erin Burke Mike Egger, Vern Sondak, John Hyngstrom Society of Surgical Oncology #SSO2022

Great to see the brilliant work of Dr. Alexander Meves Alexander Meves Mayo Clinic Mayo Clinic Comprehensive Cancer Center Mayo Clinic Department of Surgery Julia Lehman #melanoma move forward into a prospective trial!

What a team! Bringing Dr. Meves’ basic science discoveries to the patients, with translation to patients in need of better prognostic options, thanks to the hard work of Dr. His Ken and other. Well done! Alexander Meves Tina J Hieken MD

Nice synopsis of some highlights of our #melanoma practice from Alexander Meves Markovic Lab Mayo Clinic Mayo Clinic Comprehensive Cancer Center Mayo Clinic Department of Surgery Julia Lehman

@Skylinedx presents first prospective validation data Merlin Test at #eado2022. It will be the first European conference that we attend together with our collaboration partner Biocartis Click for full release 👉skylinedx.com/news/skylinedx… #precision #diagnostics in #melanoma

A Mayo Clinic Comprehensive Cancer Center study validated the use of a new test to diagnose #melanoma spread, which could previously only be detected through an invasive procedure called a sentinel lymph node biopsy. #SkinCancer mayocl.in/3PkapVg

From Mayo Clinic Mayo Clinic Comprehensive Cancer Center Mayo Clinic Department of Surgery Markovic Lab Alexander Meves #Melanoma #Immunotherapy #Genomics

SkylineDx announces #Medicare coverage for its predictive #melanoma assay Merlin Test Read full press release via this link 👇 skylinedx.com/news/skylinedx… #diagnostics #reimbursement #unitedstates #patientaccess #skincancer #skincancerawareness #skincancerawarenessmonth

⁦⁦Mayo Clinic Press⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦Alexander Meves⁩ ⁦Mayo Clinic Department of Surgery⁩ #Melanoma spread: How lymph nodes play a role in detection - Mayo Clinic Cancer Center Blog@ cancerblog.mayoclinic.org/2022/05/26/mel…

Breslow thickness 2.0: Why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies go.nature.com/3zlR402

Another information packed day #AACR2023 Excited to be here representing Mayo Clinic Mayo Clinic Comprehensive Cancer Center Mayo Clinic Department of Surgery supporting #melanoma research Alexander Meves Julia Lehman

On behalf of Vernon K Sondak MD Moffitt Cancer Center Christina Angeles MD U-M Rogel Cancer Center M Egger MD Michael Lowe Winship Cancer Institute of Emory University E Bartlett MD Memorial Sloan Kettering Cancer Center John Hyngstrom Huntsman Cancer Institute @erinburkemd E Burke MD & G Beasley MD Duke Cancer

Report by Alexander Meves et al. demonstrate plasma-based methylated DNA markers may offer a cost-effective alternative to imaging for #melanoma detection. ➡️ brnw.ch/21wFfUW #EarlyDetection #melsm

Our new BioRxiv manuscript! 🎉 "Structural and functional characterization of integrin α5-targeting antibodies for anti-angiogenic therapy" Big thanks to Alexander Meves (Mayo Clinic), Adam & Melody Campbell (UW, Fred Hutchinson), Ute Krengel (University of Oslo) and all others!

ACT NOW‼️ These proposed cuts could be devastating for not only the #melanoma community but the entire #cancer community. Contact your lawmaker today!